Project Details
Description
A study of neoadjuvant endocrine therapy versus chemotherapy in HR-positive, HER2-negative, ctDNA-negative and endocrine responsive early and locally advanced breast cancer
| Short title | ABCSG61 Teodor |
|---|---|
| Status | Active |
| Effective start/end date | 01.02.2025 → 30.06.2033 |
Fields of science
- 303 Health Sciences
- 304 Medical Biotechnology
- 305 Other Human Medicine, Health Sciences
- 302 Clinical Medicine
- 302024 Haematology
- 302055 Oncology
- 301 Medical-Theoretical Sciences, Pharmacy
- 302014 Endocrinology
- 302022 Gynaecology
- 302017 Obstetrics